PERSPECTA

News from every angle

← Back to headlines

LEQEMBI IQLIK® Autoinjector Now Available in U.S. for Early Alzheimer’s

The LEQEMBI IQLIK® (lecanemab-irmb) autoinjector is now available in the U.S. for the initiation of therapy for early Alzheimer’s disease.

24 Aug, 12:04 — 24 Aug, 12:04
PostShare

Sources

Showing 1 of 1 sources
taiwan-newsMostly Factual14h ago

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease - Taiwan News

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease  Taiwan News

Read full article →

Related Stories

Exploring Mental Health and Wellness Beyond Traditional Therapy, Including Sound Therapy

2h ago

Health Company Admits Maradona Test Mix-Up in Death Trial

2h ago

FDA Clears Roche and Eli Lilly's Alzheimer's Blood Test

4h ago

Cardiologist highlights key food for lowering cholesterol

5h ago